Nsg533 exam 1 - Study guides, Class notes & Summaries

Exam 3: NSG533/ NSG 533 (Latest 2024/ 2025) Advanced Pharmacology Complete Review| Questions and Verified Answers| 100% Correct| Grade A Q: Long-acting Inhaled B2-agonists Answer: -Provide 12-24 hours of bronchodilation after single dose -Useful for nocturnal symptoms -Chronic treatment for asthma as ADD-ON therapy for patients not controlled on low-medium dose of ICS -Helps reduce ICS amount necessary for control *-Not to be used a monotherapy (risk for severe attack)* -Salmeterol...

Exam 2: NSG533/ NSG 533 (Latest 2023/ 2024 Update) Advanced Pharmacology Exam| Questions and Verified Answers | 100% Correct| Grade A Q: When are ACEIs or ARBs added in treatment of CS/carotid artery disease? Answer: When thiazide diuretics and CCBs fail to achieve treatment goals. Q: When do you start anti-platelet therapy in patients with CS/carotid artery disease? Answer: Symptomatic for 21 days or more Q: What medication and dose are preferred anti-platelet's fo...

NSG533 / NSG 533 Exam 1 (Latest 2024 / 2025): Advanced Pharmacology | Questions and Verified Answers with Rationales | 100% Correct | Grade A - Wilkes

Exam 1: NSG533/ NSG 533 (Latest 2023/ 2024 Update) Advanced Pharmacology Exam Review| Complete Guide with Questions and Verified Answers| 100% Correct Q: What are the goals set by ACE /ACCE and are they written in stone for all patients? Answer: Primary target for glycemic control is HbA1C Individualize HbA1C goal - based on...Duration of DMAge/life expectancyComorbid conditions Known CVD or advanced comorbid conditionsHypoglycemic unawareness Individual patient considerations ...